The Management of Hyperglycemia in Noncritically ill Hospitalized Patients Treated with Continuous Enteral or Parenteral Nutrition
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Objective Hyperglycemia is a common problem in hospitalized patients receiving artificial nutrition, and this development of hyperglycemia during parenteral nutrition therapy (PNT) and enteral nutrition therapy (ENT) increases the risks of hospital-related complications and mortality. This review aims to discuss the pathogenesis of hyperglycemia from artificial nutrition in the hospital, summarize current evidence on the treatment of hyperglycemia with insulin in these patients, and review current guidelines.Methods A systematic literature review using PubMed and the Medical Subject Headings (MeSH) terms "hyperglycemia," "enteral nutrition," and "parenteral nutrition" were used to evaluate the current evidence available for treating noncritically ill patients with hyperglycemia who were receiving artificial nutrition.Results The literature review showed that few randomized control trials exist regarding treatment of hyperglycemia in this cohort of patients, and the multiple retrospective evaluations that have addressed this topic provided varied results. In general, intravenous (IV) continuous insulin infusion offers the best glycemic control; however, this route of insulin administration is often burdensome for floor patients and their care teams. Administration of scheduled subcutaneous (SQ) insulin in patients on ENT or PNT is a safe and effective way to manage hyperglycemia, however limited data exist on an appropriate insulin regimen.Conclusion Further prospective, randomized control trials are necessary to determine the optimal treatment of hyperglycemia for patients receiving ENT or PNT.Abbreviations BG = blood glucose; CG = conventional glycemic control; ENT = enteral nutrition therapy; GIP = glucose-dependent insulinotropic polypeptide; GLP-1 = glucagon-like peptide 1; IG = intensive glycemic control; IV = intravenous; NPH = neutral protamine Hagedorn; PNT = parenteral nutrition therapy; SQ = subcutaneous; T2DM = type 2 diabetes mellitus; TDD = total daily dose; TPN = total parenteral nutrition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While still investigational, consensus guidelines and experts agree that CGM may better detect and prevent hypoglycemic episodes.1390,1391”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1391]
Citations
Cites
Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes
Umpierrez, G. E., Isaacs, S. D., Bazargan, N., You, X., Thaler, L. M., & Kitabchi, A. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8341 · Cited by 2,195
Capes, S. E., Hunt, D., Malmberg, K., & Gerstein, H. C. (2000) · The Lancet · doi:10.1016/s0140-6736(99)08415-9 · Cited by 2,187
Capes, S. E., Hunt, D., Malmberg, K., Pathak, P., & Gerstein, H. C. (2001) · Stroke · doi:10.1161/hs1001.096194 · Cited by 1,824
Umpierrez, G. E., Hellman, R., Korytkowski, M. T., Kosiborod, M., Maynard, G. A., Montori, V. M., Seley, J. J., & Van den Berghe, G. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2098 · Cited by 1,126
Glucose Control Lowers the Risk of Wound Infection in Diabetics After Open Heart Operations
Zerr, M., Furnary, M., Grunkemeier, P., Bookin, M., Kanhere, M., & Starr, M. (1997) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(96)01044-2 · Cited by 913
Malmberg, K., Norhammar, A., Wedel, H., & Rydén, L. (1999) · Circulation · doi:10.1161/01.cir.99.20.2626 · Cited by 847
Early Postoperative Glucose Control Predicts Nosocomial Infection Rate in Diabetic Patients
Pomposelli, J. J., Baxter, J. K., Babineau, T. J., Pomfret, E. A., Driscoll, D. F., Forse, R. A., & Bistrian, B. R. (1998) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860719802200277 · Cited by 700
McAlister, F. A., Majumdar, S. R., Blitz, S., Rowe, B. H., Romney, J., & Marrie, T. J. (2005) · Diabetes Care · doi:10.2337/diacare.28.4.810 · Cited by 441
Furnary, A. P., Wu, Y., & Bookin, S. O. (2004) · Endocrine Practice · doi:10.4158/ep.10.s2.21 · Cited by 434
Kosiborod, M., Inzucchi, S. E., Krumholz, H. M., Xiao, L., Jones, P. G., Fiske, S., Masoudi, F. A., Marso, S. P., & Spertus, J. A. (2008) · Circulation · doi:10.1161/circulationaha.107.740498 · Cited by 385
ACG Clinical Guideline: Nutrition Therapy in the Adult Hospitalized Patient
McClave, S. A., DiBaise, J. K., Mullin, G. E., & Martindale, R. G. (2016) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.28 · Cited by 281
Hyperglycemia Is Associated With Adverse Outcomes in Patients Receiving Total Parenteral Nutrition
Cheung, N. W., Napier, B., Zaccaria, C., & Fletcher, J. P. (2005) · Diabetes Care · doi:10.2337/diacare.28.10.2367 · Cited by 226
14. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s014 · Cited by 178
Korytkowski, M. T., Salata, R. J., Koerbel, G. L., Selzer, F., Karslioglu, E., Idriss, A. M., Lee, K. K. W., Moser, A. J., & Toledo, F. G. S. (2009) · Diabetes Care · doi:10.2337/dc08-1436 · Cited by 149
The Incretin Approach for Diabetes Treatment
Holst, J. J., & Ørskov, C. (2004) · Diabetes · doi:10.2337/diabetes.53.suppl_3.s197 · Cited by 106
Ainla, T., Baburin, A., Teesalu, R., & Rahu, M. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01625.x · Cited by 75
Hsia, E., Seggelke, S. A., Gibbs, J., Rasouli, N., & Draznin, B. (2011) · Nutrition in Clinical Practice · doi:10.1177/0884533611420727 · Cited by 63
Jakoby, M., & Nannapaneni, N. (2011) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607111415628 · Cited by 59
Marathe, C. S., Rayner, C. K., Bound, M., Checklin, H., Standfield, S., Wishart, J., Lange, K., Jones, K. L., & Horowitz, M. (2014) · Diabetes · doi:10.2337/db13-1757 · Cited by 53
Drincic, A. T., Knezevich, J. T., & Akkireddy, P. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0882-3 · Cited by 47
Hongsermeier, T., & Bistrian, B. R. (1993) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860719301700116 · Cited by 42
Yuan, J., Liu, T., Zhang, X., Si, Y., Ye, Y., Zhao, C., Wang, Q., & Shen, X. (2015) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-015-2871-7 · Cited by 39
García-Rodríguez, C. E., Mesa, M. D., Olza, J., Buccianti, G., Pérez, M., Moreno‐Torres, R., de la Cruz, A. P., & Gil, Á. (2012) · European Journal of Nutrition · doi:10.1007/s00394-012-0462-x · Cited by 36
Olveira, G., García‐Luna, P. P., Pereira, J. L. S., Rebollo, I., García‐Almeida, J. M., Serrano, P., Rocamora, J. A. I., Muñoz-Aguilar, A., Molina, M. A. J., & Tapia, M. J. (2012) · PubMed · doi:10.3305/nh.2012.27.6.6076 · Cited by 34
Use of insulin glargine in patients with hyperglycaemia receiving artificial nutrition
Fatati, G., Mirri, E., Tosto, S. D., Palazzi, M., Vendetti, A. L., Mattei, R., & Puxeddu, A. (2005) · Acta Diabetologica · doi:10.1007/s00592-005-0200-4 · Cited by 31
Oghazian, M. B., Javadi, M. R., Radfar, M., Torkamandi, H., Sadeghi, M., Hayatshahi, A., & Gholami, K. (2015) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1546 · Cited by 28
Cook, A., Burkitt, D., McDonald, L., & Sublett, L. (2009) · Nutrition in Clinical Practice · doi:10.1177/0884533609351531 · Cited by 28
Predictors of Insulin Requirements Among Hospitalized Adults Receiving Parenteral Nutrition
Roehl, K., Lach, K., Coltman, A. E., Bacon, C. A., Singh, S., Peterson, S. J., & Sowa, D. C. (2013) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607113492927 · Cited by 21
Neff, K., Donegan, D. M., MacMahon, J., O'Hanlon, C., Keane, N., Agha, A., Thompson, C. D., & Smith, D. C. (2014) · PubMed · Cited by 15
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Stress hyperglycemia in acute pancreatitis: From mechanisms to prognostic implications
Guan, Y., Liu, G., Tang, F., Wu, X., Shi, J., & Huang, Q. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123469 · Cited by 20
Xiong, W., Zhang, X., Zhou, J., Tan, M.-X., Liu, Y., Yan, Y., Lei, H.-J., Peng, J.-R., Liu, W., & Tan, P. (2023) · Current Molecular Medicine · doi:10.2174/1566524023666230111163718 · Cited by 9
Hospitalization as an Opportunity to Optimize Glycemic Control in Oncology Patients
Hiestand, A., Flory, J., & Chitkara, R. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1283-6 · Cited by 9
Demidowich, A. P., Stanback, C., & Zilbermint, M. F. (2024) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.15190 · Cited by 13
“10,70,71 Bolus enteral feeds should be managed with regular or rapid-acting insulin.”
Metadata
- Authors
- Vennard, K. C., Selen, D. J., & Gilbert, M. P.
- Affiliations
- University of Vermont (US)
- Brown University (US)
- Corresponding author
- Gilbert, Matthew P.
- Venue
- Endocrine Practice
- Publisher
- Elsevier BV
- Published
- 2018-10
- Volume
- 24
- Issue
- 10
- Pages
- 900-906
- ISSN
- 1530-891X (ISSN-L)
- OpenAlex
- W2884282296
- Cited by
- 25
- References
- 29
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 4 · 2023: 1 · 2022: 4 · 2021: 3 · 2020: 1 · 2019: 4 · 2018: 1
- FWCI
- 0.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Endocrine Practice (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Nursing › Nutrition and Dietetics › Clinical Nutrition and Gastroenterology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- hyperglycemia, enteral nutrition, parenteral nutrition, insulin therapy, continuous insulin infusion, subcutaneous insulin, glycemic control, hospitalized patients, artificial nutrition, glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1, type 2 diabetes, total parenteral nutrition
- MeSH terms
- Blood Glucose, Diabetes Mellitus, Type 2, Enteral Nutrition, Hospitalization, Humans, Hyperglycemia, Hypoglycemic Agents, Parenteral Nutrition, Parenteral Nutrition, Total, Administration, Intravenous
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.